RBC Capital analyst Shagun Singh raised the firm’s price target on Intuitive Surgical to $309 from $305 and keeps an Outperform rating on the shares. The company’s Q1 revenue topped expectations thanks to strong procedure volumes and higher system placements, the analyst tells investors in a research note, adding that the management also raised its FY23 procedure volume guidance to 18%-21% from 12%-16%, reflecting strong system utilization trends. The firm sees a multi-year period of growth ahead driven by Intuitive Surgical’s "technology leadership and robust underlying market trends".
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ISRG:
- Intuitive Surgical price target raised to $285 from $265 at Morgan Stanley
- Intuitive Surgical price target raised to $325 from $300 at Truist
- Intuitive Surgical price target raised to $315 from $300 at BofA
- Intuitive Surgical price target raised to $300 from $250 at Mizuho
- Intuitive Surgical price target raised to $310 from $289 at Wells Fargo
